Extracranial stereotactic radioablation. Review of biological basis, technique and preliminary clinical experience Report uri icon

Overview

MeSH Major

  • Carcinoma, Squamous Cell
  • Chemoradiotherapy
  • Diagnostic Imaging
  • Practice Guidelines as Topic
  • Vulvar Neoplasms

abstract

  • Extracranial stereotactic radioablation (ESR) is a new and exiting treatment modality of delivering high dose, hypofractionated irradiation, to extracranial tumors. In the present article we will briefly review the rationale, biological implications of "extreme" hypofractionation, treatment technique and published data. In addition data from an ongoing Phase I clinical trial in patients with clinical stage I, medically inoperable, non-small cell lung cancer, conducted at Indiana University will be presented.

publication date

  • January 2002

Research

keywords

  • Report

Additional Document Info

start page

  • 19

end page

  • 25+i

volume

  • 25

number

  • 4